Minerva Neurosciences (NERV) Institutional Ownership $2.03 -0.03 (-1.46%) Closing price 09/19/2025 04:00 PM EasternExtended Trading$2.00 -0.03 (-1.43%) As of 09/19/2025 05:16 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Minerva Neurosciences (NASDAQ:NERV)CurrentInstitutional OwnershipPercentage34.56%Number ofInstitutional Buyers(last 12 months)3TotalInstitutional Inflows(last 12 months)$84.69KNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$64.60K Get NERV Insider Trade Alerts Want to know when executives and insiders are buying or selling Minerva Neurosciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data NERV Institutional Buying and Selling by Quarter Minerva Neurosciences Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails4/10/2025Apella Capital LLC20,625$35K0.0%N/A0.295% 2/17/2025Citadel Advisors LLC25,764$57K0.0%+49.5%0.369% 2/14/2025Northern Trust Corp36,878$82K0.0%+60.0%0.528% 2/13/2025Renaissance Technologies LLC128,100$285K0.0%-18.5%1.833% 8/9/2024Renaissance Technologies LLC167,700$535K0.0%-5.7%2.398% 11/13/2023Acadian Asset Management LLC17,423$120K0.0%-18.8%0.249% 8/7/2023Acadian Asset Management LLC21,463$195K0.0%-24.3%0.307% 7/27/2023Virtu Financial LLC20,993$192K0.0%N/A0.377% 11/14/2022Point72 Asset Management L.P.25,000$231K0.0%N/A0.468% 10/26/2022Truist Financial Corp11,043$102K0.0%N/A0.207% Get the Latest News and Ratings for NERV and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Minerva Neurosciences and its competitors with MarketBeat's FREE daily newsletter. 9/16/2022Federated Hermes Inc.1,201,275$3.98M0.0%-87.5%22.496% 2/10/2022Acadian Asset Management LLC1,768,685$1.41M0.0%+3.4%4.140% 11/16/2021Two Sigma Securities LLC16,788$29K0.0%N/A0.039% 11/15/2021Dimensional Fund Advisors LP740,056$1.29M0.0%-30.7%1.732% 11/15/2021GSA Capital Partners LLP480,629$836K0.1%+26.0%1.125% 11/12/2021Renaissance Technologies LLC754,116$1.31M0.0%-24.7%1.765% 11/12/2021Connor Clark & Lunn Investment Management Ltd.143,761$250K0.0%+33.3%0.337% 11/10/2021Rafferty Asset Management LLC48,865$85K0.0%N/A0.114% 11/9/2021BlackRock Inc.488,370$850K0.0%+20.2%1.143% 11/2/2021Raymond James Financial Services Advisors Inc.17,000$30K0.0%-54.1%0.040% 10/19/2021Assenagon Asset Management S.A.1,082,333$1.88M0.0%+44.5%2.533% 9/17/2021Virtu Financial LLC15,389$36K0.0%N/A0.036% 8/17/2021Millennium Management LLC1,294,444$3.00M0.0%+126.5%3.030% 8/17/2021Bridgeway Capital Management LLC89,200$207K0.0%-61.8%0.209% 8/16/2021Squarepoint Ops LLC15,578$36K0.0%N/A0.036% 8/16/2021AQR Capital Management LLC52,822$123K0.0%-69.3%0.124% 8/16/2021LMR Partners LLP31,189$72K0.0%N/A0.073% 8/16/2021State Street Corp110,632$257K0.0%-80.6%0.259% 8/16/2021Tibra Equities Europe Ltd136,100$316K0.1%N/A0.319% 8/16/2021Goldman Sachs Group Inc.97,564$227K0.0%-89.8%0.228% 8/13/2021Renaissance Technologies LLC1,001,844$2.32M0.0%+128.2%2.345% 8/13/2021Northern Trust Corp68,097$158K0.0%-81.5%0.159% 8/13/2021Jump Financial LLC65,600$153K0.0%N/A0.154% 8/13/2021Qube Research & Technologies Ltd15,329$36K0.0%N/A0.036% 8/13/2021Geode Capital Management LLC445,779$1.03M0.0%-35.8%1.043% 8/13/2021Vanguard Group Inc.4,098,851$9.51M0.0%-7.3%9.594% 8/12/2021XTX Topco Ltd34,202$79K0.0%N/A0.080% 8/12/2021Dimensional Fund Advisors LP1,067,481$2.48M0.0%-1.9%2.499% 8/12/2021JPMorgan Chase & Co.118,560$275K0.0%-36.0%0.278% 8/12/2021Ergoteles LLC162,100$376K0.0%N/A0.379% 8/12/2021Connor Clark & Lunn Investment Management Ltd.107,874$250K0.0%+10.3%0.253% 8/11/2021Bank of New York Mellon Corp30,757$71K0.0%-74.4%0.072% 8/11/2021Deutsche Bank AG114,523$266K0.0%+16.6%0.268% 8/4/2021Russell Investments Group Ltd.94,688$218K0.0%-7.6%0.222% (Data available from 1/1/2016 forward) NERV Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of NERV shares? During the previous two years, the following institutional investors and hedge funds held shares of Minerva Neurosciences shares: Renaissance Technologies LLC ($285K), Acadian Asset Management LLC ($120K), Northern Trust Corp ($82K), and Citadel Advisors LLC ($57K), Apella Capital LLC ($35K).Learn more on Minerva Neurosciences' institutional investors. What percentage of Minerva Neurosciences' stock is owned by institutional investors? 34.56% of Minerva Neurosciences' stock is owned by institutional investors. Learn more on NERV's institutional investor holdings. Which institutional investors have been buying Minerva Neurosciences' stock? The following institutional investors have purchased Minerva Neurosciences' stock in the last 24 months: Apella Capital LLC ($20.63K), Northern Trust Corp ($13.83K), and Citadel Advisors LLC ($8.53K). How much institutional buying is happening at Minerva Neurosciences? Institutional investors have bought a total of 42,979 shares in the last 24 months. This purchase volume represents approximately $84.69K in transactions. Which of Minerva Neurosciences' major shareholders have been selling company stock? The following institutional investors have sold Minerva Neurosciences stock in the last 24 months: Renaissance Technologies LLC ($29.10K). How much institutional selling is happening at Minerva Neurosciences? Institutional investors have sold a total of 29,100 shares in the last 24 months. This volume of shares sold represents approximately $64.60K in transactions. Related Companies Galapagos Major Shareholders Indivior Major Shareholders InterCure Major Shareholders IO Biotech Major Shareholders MediciNova Major Shareholders Neonc Technologies Major Shareholders This page (NASDAQ:NERV) was last updated on 9/21/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Minerva Neurosciences, Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Minerva Neurosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
